Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of a Video-based Information Intervention on Family Outcomes in Neurocritical Care (WELFARE)

13. november 2026 oppdatert av: University Hospital, Caen

Effect of a Video-based Information Intervention on Family Outcomes in Neurocritical Care: Study Protocol for the WELl-being of FAmily in Neurocritical caRE Unit (*WELFARE*) Randomised Controlled Trial

The trial was designed to determine whether on-demand access to educational videos about neurocritical care, in addition to usual family support, reduces the prevalence of post-traumatic stress symptoms among relatives 3 months after intensive care unit admission. The expected finding is a lower prevalence of post-traumatic stress symptoms among relatives given access to the videos.

Studieoversikt

Detaljert beskrivelse

This study is a superiority trial. Relatives are randomly assigned in a 1:1 ratio to the control or intervention group, using permuted blocks of variable size.

Studietype

Intervensjonell

Registrering (Antatt)

180

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Caen, Frankrike, 14033
        • Caen University Hospital (CHU de Caen Normandie)
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Primary relative of a patient admitted to an adult intensive care unit for a traumatic brain injury or a stroke (haemorrhagic or ischaemic).
  • The primary relative is designated according to the following order of priority: the trusted person (personne de confiance) or, failing that, the designated family member or, failing that, the designated close person.
  • Age of the primary relative greater than or equal to 18 years.
  • The primary relative is not under legal guardianship.
  • French-speaking primary relative.
  • Primary relative affiliated with a social security scheme.
  • Primary relative who has signed an informed consent form.

Exclusion Criteria:

  • Primary relative under 18 years of age
  • Psychiatric disorder under drug treatment
  • Non-French-speaking primary relative
  • Refusal to participate in the study by the primary relative
  • Primary relative not affiliated with a social security scheme
  • The primary relative is a pregnant woman

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Usual family support

At inclusion, the unit's paper welcome booklet is given to relatives during a family meeting with a physician, the nurse and the nursing assistant in charge of the patient. The team answers their questions, explains the patient's condition, treatment and prognosis, and presents the unit's visiting and appointment policy. During the stay, meetings are organised to review the patient's condition, diagnosis, prognosis and treatment, according to unit practice. Visits, telephone calls and meetings with the healthcare team are free, limited only by the unit's visiting rules and staff availability.

Eksperimentell: Usual family support plus access to the educational videos

At inclusion, the unit's paper welcome booklet is given to relatives during a family meeting with a physician, the nurse and the nursing assistant in charge of the patient. The team answers their questions, explains the patient's condition, treatment and prognosis, and presents the unit's visiting and appointment policy. During the stay, meetings are organised to review the patient's condition, diagnosis, prognosis and treatment, according to unit practice. Visits, telephone calls and meetings with the healthcare team are free, limited only by the unit's visiting rules and staff availability.

The videos were produced by the unit's healthcare professionals. Access is free and unlimited, on demand, on a secure website, throughout the patient's intensive care unit stay. They retrace the chronology of the care pathway of a neurocritical care patient and answer questions frequently asked by families during meetings with the team, for example about the patient's room and environment, the equipment used, the staff, and the procedures performed and their purpose.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Prevalence of post-traumatic stress symptoms
Tidsramme: 3 months

Post-traumatic stress symptoms is defined as an Impact of Event Scale-Revised total score above 30. The Impact of Event Scale-Revised is a 22-item self-report questionnaire measuring subjective distress caused by a traumatic event (total score 0-88).

3 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Family satisfaction
Tidsramme: 3 month

Family satisfaction is measured with the Family Satisfaction in the Intensive Care Unit questionnaire. It evaluates two main areas: satisfaction with patient care and satisfaction with communication and decision-making involving healthcare professionals.

3 month
Depressive symptoms
Tidsramme: 3 month

Depressive symptoms are defined as a Hospital Anxiety and Depression Scale depression subscore above 7. It is a validated self-report questionnaire. It consists of seven items assessing feelings such as loss of enjoyment, reduced interest and decreased motivation over the previous week, with scores ranging from 0 to 21.

3 month
Anxiety symptoms
Tidsramme: 3 months

Anxiety symptoms are defined as a Hospital Anxiety and Depression Scale anxiety subscore above 7. It is a validated self-report questionnaire. It consists of seven items assessing feelings of anxiety and worry over the previous week, with scores ranging from 0 to 21.

3 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. februar 2029

Studiet fullført (Antatt)

1. februar 2029

Datoer for studieregistrering

Først innsendt

6. november 2026

Først innsendt som oppfylte QC-kriteriene

13. november 2026

Først lagt ut (Faktiske)

16. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. november 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere